Heberprot-p was created by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB)
The next meeting of the Russia-Cuba Health Working Group Intergovernmental Commission will be held in May
Unique in the world to treat advanced foot ulcers in diabetic patients, the Cuban drug Heberprot-P has already been registered in 23 countries, it was informed today
Cuba reduced by over 78 percent the relative risk of amputation due to diabetic foot ulcers, thanks to a comprehensive program of care for these patients that includes the use of the drug Heberprot-P.
Russia’s Health Minister Veronika Skortsova stressed in Moscow the quality of the Cuban biotechnology industry and expressed her interest in having a larger presence of Cuban pharmaceuticals in her country.
Eighty-four percent of Cubans with diabetes mellitus have a life expectancy of nearly 78 years, similar to that of those who have not suffered the disease, the Granma newspaper reported.
The Cuban product Heberprot-p, to cure complaints resulting from diabetes, is welcomed in Ecuador for the results reported by patients with treatment in this South American country.
Heberprot-P, the only product in the world capable of curing diabetic foot ulcers, has benefited over 60,000 people in the world since its registration in Cuba in 2006, announced an expert.
The Cuba-made medication Heberprot-P, used in the treatment of diabetic foot ulcers, has entered the second phase of clinical trials in Europe.
Although estimates tend to be inaccurate, presumably over 28 000 people in Sancti Spiritus, central Cuba, suffer from diabetes. The figure itself is quite alarming, mainly because of the effects of this disease, responsible for severe disorders in an individual’s health.